Related Experiment Videos
Chromosome telomere integrity of human solid neoplasms
M G Butler1, M Sciadini, L K Hedges
1Department of Orthopedics, Vanderbilt University Medical Center, Nashville, TN 37232-2578, USA.
Cancer Genetics and Cytogenetics
|January 1, 1996
Summary
Telomere reduction, crucial for chromosome stability, was investigated in various cancers. Significant telomere shortening was observed in several malignancies, but not universally across all cancer types studied.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Telomeres are protective DNA structures at chromosome ends, vital for replication and stability.
- Telomere shortening is linked to genetic instability and observed in specific cancers like colon cancer and leukemia.
- The generalized occurrence of telomere reduction across diverse malignancies remains to be fully elucidated.
Purpose of the Study:
- To investigate telomere integrity in a broad spectrum of human malignancies.
- To determine if telomere reduction is a common feature across different cancer types.
- To compare telomere lengths in tumor cells versus normal leukocytes.
Main Methods:
- Genomic DNA was isolated from tumor cells of 39 patients with 15 distinct malignancies.
- Telomere integrity was assessed in tumor DNA and, where possible, in peripheral blood leukocytes from the same patients or age-matched controls.
- Malignancies were categorized into musculoskeletal, epithelial, cranial, and other groups for analysis.
Main Results:
- Significant telomere reduction was observed in specific malignancies, including giant cell tumor of bone, glioblastoma, colon cancer, and Wilms' tumor.
- Conversely, telomere elongation was noted in chordoma.
- Ten other malignancies showed no significant difference in telomere length compared to controls.
Conclusions:
- Telomere reduction is not a universal phenomenon in all malignancies.
- Specific cancer types exhibit distinct alterations in telomere length, suggesting varied roles in tumorigenesis.
- Further research is needed to understand the specific mechanisms driving telomere changes in different cancers.